@article {Stephens532, author = {Jeffrey Wayne Stephens and David M Williams and Richard Chudleigh}, title = {Diabetes mellitus: what the neurologists need to know}, volume = {22}, number = {6}, pages = {532--539}, year = {2022}, doi = {10.1136/pn-2022-003395}, publisher = {BMJ Publishing Group Ltd}, abstract = {Diabetes mellitus is a common condition associated with numerous complications and comorbidities. The diabetes spectrum includes type 1, type 2 and other forms of diabetes, which may be associated with medical therapies and genetic factors. Type 2 diabetes is managed with lifestyle, oral therapies, non-insulin-based injectables and subsequently insulin. Type 1 diabetes requires insulin from the time of diagnosis. In recent years, there have been considerable developments in the therapies available to treat type 2 diabetes and some of these also afford cardiorenal protection. This review summarises the nature, complications and therapeutic advances in the field of diabetes and provides a concise review for neurologists. Managing diabetes optimally prevents complications and all medical specialties need a basic understanding of the principles involved in diabetes care.No data are available.}, issn = {1474-7758}, URL = {https://pn.bmj.com/content/22/6/532}, eprint = {https://pn.bmj.com/content/22/6/532.full.pdf}, journal = {Practical Neurology} }